Connecting to Apple Music.
This podcast features malaria experts Caroline Boulton (Global Program Head, Malaria, at Novartis); Sherwin Charles (CEO, Goodbye Malaria); and Carlos Chaccour (Researcher and Visiting Scholar, Navarra Institute for International Development). The conversation delves into the current malaria response, examining shifts in international funding, R&D innovations, drug resistance challenges, emerging prevention tools, and the impact of climate change.The podcast is hosted by IQVIA's Daniel Mora-Brito, Engagement Manager, Global Health, EMEA Thought Leadership.
In this episode, IQVIA MedTech experts Michelle Edwards and Michaela Miller discuss key trends shaping the MedTech industry in 2025. The conversation covers advancements in 3D printing, real-world evidence (RWE), and clinical AI, among others. Read Ten MedTech Trends to Watch in 2025 to learn more. https://www.iqvia.com/locations/united-states/library/insight-brief/ten-medtech-trends-to-watch-in-2025Host: Michaela Miller, Practice Lead, U.S. MedTech Technology & Analytics, IQVIAFeatured Speaker: Michelle Edwards, Practice Lead, U.S. MedTech Real World and Clinical Solutions, IQVIA
This podcast episode features a discussion between Jeff Pilch from IQVIA and Sanjay Mistry from Molnlycke. Together, they explore the journey of how their companies collaborated to solve a significant business problem related to customer master data management (MDM). Sanjay explains the challenges Molnlycke faced in defining and managing customer data across different units, which hindered their ability to perform basic analytics and customer segmentation. Jeff and Sanjay then discussed the solutions proposed by IQVIA, emphasizing a practical, incremental approach to implementing MDM and data governance, which helped Molnlycke achieve better data management and business efficiency.Featured Speakers:Jeff Pilch - MDM Practice Lead, IQVIA Sanjay Mistry - Director Data Operations, Commercial Excellence at Molnlycke
On International HPV Awareness Day, Dr. Nicola Paul hosts Dr. Tando Gaqana, a passionate HPV vaccine advocate, and Daniel Mora-Brito, IQVIA's thought leader in global health, to discuss the impact of Human Papillomavirus (HPV) in South Africa, highlighting the importance of vaccination and regular screening to prevent HPV-related conditions in Africa.
This episode focuses on using AI for indication selection and prioritization to optimize the value of clinical development planning. In this episode you will: Discover how AI can ensure faster, better clinical development and decision making to help get drugs to market faster. See how AI can be leveraged to prioritize hundreds of indications into high-potential opportunities rapidly. Learn about using AI to look at clinical trial data to help predict the future competitive intensity for an indication. Speaker: Raja Shankar, Vice President of Machine Learning in IQVIA's Research and Development Solutions.
In this episode, Ekra Yao shares his view of the ongoing efforts and strategies in the fight against polio in Africa.
In our first episode, we discuss the efforts to eradicate polio in Africa region. Emmanuel Obagha speaks with Nelia Langa on her role as an epidemiologist tackling the disease, the progress made in Africa, and the challenges posed by vaccine-derived polio viruses. They also delve into the importance of community engagement and the key challenges and potential strategies for overcoming them.
In this episode, Dr. Vishakha Sharma, Senior Principal Data Scientist at Roche Diagnostics shares her perspectives on the potential of GenAI to improve patient outcomes, enhance the efficiency of healthcare delivery, and reduce costs. She also addresses some of the key issues surrounding data interoperability and data integration when dealing with diverse data sources and unstructured data. The discussion brings attention to the need for guiding principles and highlights the ethical frameworks.Host: Michaela Miller, Practice Lead, U.S. MedTech Technology & Analytics, IQVIAFeatured Speaker: Vishakha Sharma, Ph.D., Senior Principal Data Scientist, Roche Diagnostics
Join IQVIA Thought Leaders, Kirstie Scott and Stefan Lutzmayer, to explore how to translate the promise of ground-breaking oncology therapies into commercially successful launches. Learn about the evolving oncology landscape, and how to navigate a fluid and challenging commercial environment to achieve Oncology Launch Excellence.
In this episode you will: Discover how AI can predict the success of clinical trials in terms of efficacy, regulatory approval, operational feasibility, reimbursement attainment and product uptake. Learn why AI can give us deeper insights by analyzing unstructured data for better-informed clinical development decisions. See how an agentic AI approach can speed up what would take months and weeks manually, to days and hours, while looking at even more information for the analysis. Speaker: Raja Shankar, Vice President of Machine Learning in IQVIA's Research and Development Solutions
Tune in to the latest episode of the IQVIA SFE Insights Podcast as Lakshdeep Singh, Senior Principal at IQVIA, and Goksu Dogan, Senior Principal in the Artificial Intelligence and Machine Learning Solutions team, explore the role of predictive analytics and real-time triggers in optimizing HCP engagement and improving patient outcomes. Discover how AI/ML-powered solutions are revolutionizing the pharmaceutical industry and providing actionable insights that drive better business results. Don't miss this insightful discussion!
IQVIA Vice President for Clinical Operations Gjon Mirdita who oversees site management in the EMENA region shares his impressions on clinical operations from his recent visit to Egypt and Saudi Arabia, including the potential of clinical operations in these countries and the Middle East as a whole, IQVIA's work and cooperation with stakeholders in the region, and the development and growth of the teams and the individuals.
In this episode, Dr. Vishakha Sharma, Senior Principal Data Scientist at Roche Diagnostics, shares her perspectives on the potential of Generative AI (GenAI) to improve patient outcomes, enhance the efficiency of healthcare delivery, and reduce costs. She also addresses some of the key issues surrounding data interoperability and data integration when dealing with diverse data sources and unstructured data. The discussion brings attention to the need for guiding principles and highlights the ethical frameworks released by the World Health Organization. Host: Michaela Miller, Practice Lead, U.S. MedTech Technology & Analytics, IQVIAFeatured Speaker: Vishakha Sharma, Ph.D., Senior Principal Data Scientist, Roche Diagnostics
Elyse Munoz, IQVIA's US Director of Research and Insights, joins the podcast to discuss insights from the second paper of a three-part series, all about optimizing a US launch. Expect to learn about what impacts the optimization phase of a US launch: patient adherence, market access in the US context (and how it's different from Europe), and direct-to-consumer advertising (prohibited in other major markets).
IQVIA's Vice President for Tech & Services in the Middle East, Rauf Mohamed spoke with Johnson & Johnson Managing Director for Innovative Medicine in the Gulf Region, Pedro Matos Rosa about lung cancer in the region. Pedro and Rauf discussed the severity of lung cancer and its prevalence throughout the region, key stats and insights, the progress in the fight against this cancer, and the need for more initiatives in the region to help fight against lung cancer.
In 2023, the WHO and the World Bank recognized Egypt's remarkable achievement in eradicating hepatitis C. This podcast features a special guest, H.E. Dr. Mohamed Hassany, Assistant to the Minister of Health for Public Health and Presidential Initiatives in Egypt, who shares the nation's journey from having one of the highest incidence rates of hepatitis C to its successful elimination, and shares lessons and insights on how the strategy that was implemented can be adapted in other low- and middle-income countries.
In episode 8, IQVIA EMEA Thought Leaderships' lead on patient engagement, Meike Madelung, joins the podcast to talk about why patient engagement and support services (PES) are important for launch. Hear examples of how PES can benefit patients, healthcare systems, and pharma companies striving for launch success.
This podcast episode explores how data-driven solutions are transforming the healthcare industry. Our guest is Bob Forcier, a key figure at Smith and Nephew who plays a pivotal role in leveraging data for operational improvements. Bob shares insights on how Smith and Nephew define operational efficiency and the critical role OneKey data plays in achieving it. He and OneKey's Charles Wallace, Associate Director Product Offering, discusses the integration process, quantifiable metrics, and the benefits of using OneKey data. Listen to the podcast to learn about Smith and Nephew's success story and how OneKey has streamlined their operations.Featured speakers:Charles Wallace, OneKey Associate Director Product Offering, IQVIABob Forcier, Director, Smith and Nephew
Omnichannel is now a top priority for most pharma brand and commercial leaders. There's a clear focus to embed omnichannel engagement and drive differentiating, consumer-like experiences within campaign plans and brand strategies. And while every organization is at a different maturity level, at IQVIA, we have seen a common trend that progress, regardless of your maturation, is harder and more limited than ever. In this podcast, IQVIA's Matthew Smith and Matthew Doyle host a roundtable discussion with Takeda's Chris Weber, Head of Customer Experience, U.S. Oncology, Julia Allen, Product Marketing Director, from Fresenius Medical Care, and Eisai's Jared Shechtman, Marketing Technology Solutions, who share their unique perspectives on where the pharma industry currently stands with omnichannel transformations, the challenges related to execution, and what's needed to be more successful in 2024 and beyond.
In today's complex healthcare landscape, understanding your customers is more challenging than ever, and as such, medical device and diagnostic line partners face significant gaps and unmet needs for their commercial teams. IQVIA's latest solution, the MedTech Market Activator, fueled with OneKey data, empowers commercial teams with comprehensive insights and tools to support strategic growth and daily activities. Tune in to this podcast to learn from data and product experts about how the MedTech Market Activator will provide your teams the agility needed to make a greater impact.Featured Speakers:Shauntell Kelley, Director of OneKey Product and Strategy, IQVIAChristian Brilliant, Director and Product Owner of MedTech Market Activator, IQVIA MedTechHarry Tomaszewski, Solutions Specialist, IQVIA MedTech
In episode 2, we examine financial assistance or case management: What is a case management approach and the importance of looking at the whole patient journey.
In this episode, we examine the needs of patients in the current health systems and the role and potential of patient support programs to improve patient access to reliable and innovative treatments.
Tune in as Paige Desmarais, IQVIA SFE Principal, and Ruoxin Li, IQVIA Sr Director in Advanced Analytics, delve into the transformative impact of AI and machine learning on healthcare analytics. In this episode, they explore how these technologies are reshaping provider referral patterns. As patient and provider journeys become increasingly complex, analytics managers and brand product managers seek innovative strategies to identify referral networks more effectively.
Clinical trials play a significant role in the development of drugs and medical breakthroughs. They are key for the advancement of medicine, although not all stakeholders are aware of their of their strong impact on patient care. Listen to our podcast with guest speaker Dr. Nawal Al-Kaabi Senior Advisor and Consultant, Pediatric Infectious Disease at Sheikh Khalifa Medical City who will walk us through the landscape of clinical trials in the UAE and the region, with a focus on the COVID-19 clinical trial program.
In this episode, Dr. Shelly Nash, Senior Vice President and Global Chief Medical Information Officer at Fresenius Medical Care, discusses the importance of health equity and access to care in driving better health outcomes. Dr. Nash defines the issue of health equity and shares initiatives and opportunities for medical device and diagnostic companies to accelerate progress and address hurdles along the way. Key highlights include the challenges of data integration and interoperability. Host: Michaela Miller, Practice Lead, U.S. MedTech Technology & Analytics, IQVIAFeatured Speaker: Shelly Nash, DO, FACOOG, Senior Vice President, Global Chief Medical Information Officer, Fresenius Medical Care
IQVIA's Vice President for Genomics and Precision Medicine Joanne Hackett discusses the importance of connected care, digital maturity, and innovation and technology in healthcare.
Learn about the progress and challenges facing the Expanded Program on Immunization in Nigeria.
In this episode, Sarah Rickwood and Stefan Lutzmayer discuss key findings from the “From Orphan to Opportunity: Mastering Rare Disease Launch Excellence” white paper. Discover how to navigate the complex rare disease landscape, overcome post-pandemic hurdles, and apply the three pillars of launch excellence to achieve success in rare diseases.
In this episode, IQVIA's Raj Stewart and Michelle Edwards dig deeper into IQVIA's annual “Ten MedTech Trends to Watch” report, which focuses on the key trends impacting the U.S. MedTech industry today. Learn how health equity, the consolidation of health systems, and advances in diagnostics are impacting the need for evidence generation among MedTech manufacturers and suppliers.Read Ten MedTech Trends to Watch in 2024 to learn more. Host: Michaela Miller, Practice Lead, U.S. MedTech Technology & Analytics, IQVIAFeatured Speakers: Michelle Edwards, Practice Lead, U.S. MedTech Real World and Clinical Solutions, IQVIARaj Stewart, Principal, MedTech Market Access, IQVIA
This episode focuses on Patient Centricity in Design and how engaging patients in protocol design can improve clinical outcomes. IQVIA's Patient Centricity in Design solution helps sponsors optimize study design for patient engagement and patient outcomes, such as incorporating diverse patient preferences, selecting design elements that align with real-world patient experiences and using this knowledge to minimize patient burden. Ivan Petrov, Associate Design Analytics Director is our featured speaker.
Sarah Rickwood is joined by Elyse Muñoz, IQVIA's US Director of Research & Insights, to discuss the first of a three-part launch excellence series on the current state of US launch and the new rules for launching excellently in the US, the most important market for global innovative medicines success.
Dive into the world of data management with “Consumer Health Edge” podcast's latest episode, “Mastering Data; A Beginner's Guide to Information Management.” Join host Vaishnavi Save as she welcomes Antonello Moscatelli, a seasoned expert with nearly two decades of experience in Data and Analytics. Together, they explore the crucial steps organizations must take to implement effective information management strategies. From aligning data strategy with business objectives to assessing the data landscape and ensuring security and compliance, this episode offers actionable insights and practical tips. Discover how to harness the power of data to drive informed decision-making, enhance efficiency, and gain a competitive edge in today's dynamic market landscape. Tune in and empower your organization with the knowledge to unlock the full potential of your data assets.
Dr. Larisse Prinsen provides an overview of challenges, changes required, and implications of the NHI, from a legal perspective.
Rare Diseases, though individually uncommon, collectively affect a significant number of people. In the Middle East, these conditions present a unique set of challenges and opportunities. Tune into the final part of our podcast as we uncover how the Middle East is tackling these uncommon conditions and shed the light on what rare diseases mean to the region, from healthcare challenges to the latest advancements.
Rare Diseases, though individually uncommon, collectively affect a significant number of people. In the Middle East, these conditions present a unique set of challenges and opportunities. Tune into the first of our 2-part podcast as we uncover how the Middle East is tackling these uncommon conditions and shed the light on what rare diseases mean to the region, from healthcare challenges to the latest advancements.
In Episode 2 of our Consumer Health Edge podcast, Vaishnavi Save and Ankit Gupta delve into the dynamic world of data-driven customer journeys, sales, and distribution. We uncover the pivotal role of data analytics in optimizing shelf space for consumer health companies, suggesting how tools revolutionize in-store strategies. Understanding the consumer journey is paramount, with insights gathered from loyalty programs, social platforms, and primary market research. We explore the meticulous process of cleansing and storing data, essential for extracting actionable insights through diagnostic, descriptive, predictive, and prescriptive analytics. Moreover, we unravel the nuanced landscape of sales and distribution optimization, where data empowers companies to fine-tune their strategies, maximize revenue, and identify growth opportunities. Join us as we unravel the intricate web of data-driven healthcare strategies, offering a glimpse into the future of the industry.
Prof. Nicholas Crisp discusses South Africa's National Health Insurance, its potential, the reforms, changes, challenges, and the roles of the public and private sectors.
IQVIA invited Eric Grant, the Communications and Media Manager for the Union for International Cancer Control (UICC), to delve into the critical issue of the cancer care gap in low- and middle-income countries (LMICs) across the Middle East and Africa, shedding light on the challenges these countries encounter while striving to bridge this gap and the efforts being made.
Welcome back to IQVIA Digital Enablement's podcast series: Personalization Science. This is part 2 of our conversation with Jason Patterson, Chief Analytics Officer at Publicis Health Media. This time, host Andrew Burkus, leads an insightful discussion on the future of measurement and optimization, the role AI may play in this evolution, and how all these elements will continue to drive better health outcomes. Learn more about IQVIA Digital Enablement here: https://www.iqvia.com/locations/united-states/solutions/digital-enablement-center-of-excellence
Prof. Roseanne Harris, Health Policy Actuary at Discovery Health, discusses South Africa's National Health Insurance, its potential, the reforms and changes, and the roles of the public and private sectors.
Welcome back to IQVIA Digital Enablement's podcast series: Personalization Science. This week, we are joined by Jason Patterson, Chief Analytics Officer at Publicis Health Media, a top healthcare media agency built for the modern marketplace. In part 1 of this conversation, host Andrew Burkus and Jason dive into the world of healthcare media optimization, misconceptions in the industry, and how continuous optimization differs from campaign measurement. Learn more about IQVIA Digital Enablement here: https://www.iqvia.com/locations/united-states/solutions/digital-enablement-center-of-excellence
IQVIA South Africa General Manager Sandri Yssel presents an overview of the South Africa National Health Insurance Program and the podcast series.
In the first episode of IQVIA Digital Enablement's new podcast series, host Andrew Burkus, Sr. Principal, is joined by Amanda Powers-Han, Chief Marketing Officer at Greater Than One, a leading marketing communications agency dedicated to healthcare. Tune in as these industry experts define what personalization is, why it is essential for your audience engagement strategy, and how to drive better outcomes in healthcare and life sciences marketing. Learn more about IQVIA Digital Enablement here: https://www.iqvia.com/locations/united-states/solutions/digital-enablement-center-of-excellence
What if clinical trial sites could focus entirely on research? What if sponsors could have immediate access to trial patients during and after the study, and use those insights to improve trial design? What if all of that could be done without burdening an already strained site? What if those didn't have to be “what ifs”? In this sponsored episode of The Top Line, Julia Douthart talks to Jessica Jones, Director of Strategic Technology Delivery and Experience Optimization at IQVIA, about how new technologies are changing clinical trials, reducing the administrative burden on staff and improving insights for sponsors.But can it be done without adding an additional technological burden and learning curve on the site staff? Listen below to learn how IQVIA is addressing these challenges.
"Essentially, this allows our clinical researchers to improve the chances of success for the trial leading to faster, more efficient drug development… Ultimately, this is going to benefit patients.”Greg Lever is speaking about the use of flexible modeling to allow real-time changes to be made to clinical trial design and processes. As a director within the IQVIA Applied Data Science Center, and with over a dozen years of experience in the field, Greg knows the importance of data and advanced analytics in generating accurate patient insights to underpin key trial decision-making.By making clinical trials more patient friendly, he states, the more likely it is that research organizations will be able to attract and retain the participants they need to bring life-saving treatments to patients.In this podcast, Greg outlines how modeling can be used to enhance the entire patient journey, from the initial giving of informed consent right through to the trial's close.
In this episode, Sarah Rickwood and Kirstie Scott discuss key findings from the “Success Multiplied: Launch Excellence for Multi-Indication Assets” white paper. Learn about the specific challenges multi-indication assets face, such as sequencing and speed of indication roll-out, performance consistency across multiple indications and promotional investment strategies to capture pan-indication synergies.
In part two, Andrew Jones shares just how much data is available in IQVIA's Infinite Dimension Profiler. Tune in and learn how you can build healthcare professional profiles that include both professional and personal dimensions. He also shares how the platform opens up data silos, relieving IT headaches, and allows you to build true omnichannel programs. If you missed part one, catch up for an overview of the Infinite Dimension Profiler. Featured Speakers:Kathleen Aalderink, Director, OneKey Digital Enablement, IQVIA Andrew Jones, Product Manager, Global Information Management, IQVIA
Do you have a complete picture of the healthcare professionals (HCPs) in your universe? Are you able to dynamically target and message them as market events change? If you don't, or even if you think you do, tune into this podcast where IQVIA's Kathleen Aalderink and Andrew Jones discuss all things around joining and leveraging data to build and compare target audience profiles. You will hear how the Infinite Dimension Profiler will help you pinpoint the right HCPs, which in turn, increases the speed in which your therapies reach patients. Be sure to tune into part two; you'll be impressed to hear about the incredible amount of data you can have at your fingertips.Featured Speakers:Kathleen Aalderink, Director, OneKey Digital Enablement, IQVIA Andrew Jones, Product Manager, Global Information Management, IQVIA
This final episode focuses on the authority of physician assistants and naturopathic physicians. The conversation goes beyond the latest state-level authority regulations and includes a sampling of the varying definitions of what a naturopathic physician is. The speakers also share insight into what you can expect around prescriptive authority in the future. Be sure to tune into this episode, but to get the most out of our Prescriptive Authority series, take the opportunity to listen to parts one and two as well. Featured Speakers: Shauntell Kelley, Associate Director, Digital Solutions Offering Management, IQVIALiz Updike, Director & Sr. Managing Attorney U.S. Client Services, IQVIA
Dive into the world of data-driven healthcare in the inaugural episode of "Consumer Health Edge." Join host Vaishnavi Save and industry expert Raj Jawalkar, with over two decades of experience, as we explore the game-changing role of predictive analytics. Discover strategies for sustainable success, the importance of a well-defined business objective, and the critical pillars of data transformation. Raj unravels the complexities of sourcing, processing, and integrating data for effective predictive models.Raj also provides insights into customer analysis for diverse industry groups—sales, pharmacies, marketing, and e-commerce. Learn how companies leverage predictive models to enhance effectiveness and drive strategic decisions in these domains.This episode speaks about the foundations of successful predictive analytics, offering tangible examples and expert insights. Don't miss out on this engaging discussion that unveils the intricate world of data-driven healthcare and its transformative impact on sales and marketing.Tune in now for a journey through the evolving landscape of consumer health!
Eric Klaver, DCT Regulatory Director, shares how IQVIA supports investigators within the areas of clinical trial conduct and operations.